HomeADVM • NASDAQ
Adverum Biotechnologies Inc
$14.14
Mar 28, 6:09:04 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$14.66
Day range
$13.83 - $14.82
Year range
$6.81 - $29.70
Market cap
293.47M USD
Avg Volume
235.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
0.00
Operating expense
10.66M23.66%
Net income
-23.71M27.56%
Net profit margin
Earnings per share
-2.3030.30%
EBITDA
-24.92M9.08%
Effective tax rate
4.56%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
96.53M-47.99%
Total assets
173.01M-43.90%
Total liabilities
89.54M-29.41%
Total equity
83.47M
Shares outstanding
20.75M
Price to book
1.78
Return on assets
-35.07%
Return on capital
-38.51%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-23.71M27.56%
Cash from operations
-21.33M-15.44%
Cash from investing
-9.88M-542.17%
Cash from financing
166.00K-31.40%
Net change in cash
-31.04M-94.01%
Free cash flow
-14.00M-189.85%
About
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Founded
Jan 1, 2006
Employees
121
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu